Depression in relation to biochemical parameters and age in women with polycystic ovary syndrome

European Journal of Obstetrics and Gynecology and Reproductive Biology

Volumn 184, Issue , 2015, Pages 43-47

  Klimczak, Dominika ^a   Szlendak Sauer, Katarzyna ^a   Radowicki, Stanisław ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Androgens; Biochemical parameters; Depression scores; Lipid profile; Polycystic ovary syndrome

Indexed keywords

ANDROGEN; ANDROSTENEDIONE; GLUCOSE; HIGH DENSITY LIPOPROTEIN; HYDROCORTISONE; LOW DENSITY LIPOPROTEIN; PRASTERONE SULFATE; PROLACTIN; TRIACYLGLYCEROL; LIPID;

ADULT; ANDROGEN BLOOD LEVEL; ARTICLE; BECK DEPRESSION INVENTORY; BIOCHEMISTRY; BODY MASS; DEPRESSION; FEMALE; GLUCOSE METABOLISM; GYNECOLOGICAL EXAMINATION; HUMAN; HYPERANDROGENISM; LIPID BLOOD LEVEL; MAJOR CLINICAL STUDY; METABOLIC PARAMETERS; OBSERVATIONAL STUDY; OVARY POLYCYSTIC DISEASE; PATIENT HEALTH QUESTIONNAIRE 9; PREVALENCE; PRIORITY JOURNAL; PSYCHOLOGIC ASSESSMENT; TRANSVAGINAL ECHOGRAPHY; WAIST CIRCUMFERENCE; AGE; BLOOD; COMORBIDITY; CROSS-SECTIONAL STUDY; POLYCYSTIC OVARY SYNDROME; PSYCHOLOGY; YOUNG ADULT;

ADULT; AGE FACTORS; ANDROSTENEDIONE; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEHYDROEPIANDROSTERONE SULFATE; DEPRESSION; FEMALE; HUMANS; LIPIDS; POLYCYSTIC OVARY SYNDROME; PREVALENCE; WAIST CIRCUMFERENCE; YOUNG ADULT;

EID: 84920605468     PISSN: 03012115     EISSN: 18727654     Source Type: Journal    
DOI: 10.1016/j.ejogrb.2014.10.028     Document Type: Article

References (34)

1. W.A. March, V.M. Moore, and K.J. Willson The prevalence of polycystic ovary syndrome in a community sample assessed under contrasting diagnostic criteria Hum Reprod 25 2010 544
2. E.S. Knochenhauer, T.J. Key, and M. Kahsar-Miller Prevalence of the polycystic ovary syndrome in unselected black and white women of the southeastern United States: a prospective study J Clin Endocrinol Metab 83 1998 3078
3. R. Azziz, K.S. Woods, and R. Reyna The prevalence and features of the polycystic ovary syndrome in an unselected population J Clin Endocrinol Metab 89 2004 2745
4. E. Diamanti-Kandarakis, C.R. Kouli, and A.T. Bergiele A survey of the polycystic ovary syndrome in the Greek island of Lesbos: hormonal and metabolic profile J Clin Endocrinol Metab 84 1999 4006
5. M. Asunción, R.M. Calvo, and J.L. San Millán A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain J Clin Endocrinol Metab 85 2000 2434
6. K.F. Michelmore, A.H. Balen, D.B. Dunger, and M.P. Vessey Polycystic ovaries and associated clinical and biochemical features in young women Clin Endocrinol (Oxf) 51 1999 779
7. F.R. Tehrani, M. Simbar, and M. Tohidi The prevalence of polycystic ovary syndrome in a community sample of Iranian population: Iranian PCOS prevalence study Reprod Biol Endocrinol 9 2011 39
8. S. Benson, O.E. Janssen, and S. Hahn Obesity, depression, and chronic low-grade inflammation in women with polycystic ovary syndrome Brain Behav Immun 22 2008 177 184
9. E. Jedel, D. Gustafson, and M. Waern Sex steroids, insulin sensitivity and sympathetic nerve activity in relation to affective symptoms in women with polycystic ovary syndrome Psychoneuroendocrinology 36 2011 1470 1479
10. Z.A. Brown, Y.V. Louwers, and S. Lie Fong The phenotype of polycystic ovary syndrome ameliorates with aging Fertil Steril 96 November (5) 2011 1259 1265
11. I. Hsu Ming Changes in the PCOS phenotype with age Steroids 78 8 2013 761 766
12. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS) Hum Reprod 19 2004 41
13. R.S. Legro, S.A. Arslanian, D.A. Ehrmann, K.M. Hoeger, M. Hassan Murad, and R. Pasquali Diagnosis and treatment of polycystic ovary syndrome: an endocrine society clinical practice guideline J Clin Endocrinol Metab 98 2013 4565 4592
14. K. Kroenke, R.L. Spitzer, and J.B. Williams The PHQ-9: validity of a brief depression severity measure J Gen Intern Med 16 2001 606
15. K. Kroenke, and R.L. Spitzer The PHQ-9: a new depression and diagnostic severity measure Psychiatr Ann 32 2002 509
16. A.J. Rush, M.H. Trivedi, and H.M. Ibrahim The 16-Item Quick Inventory of Depressive Symptomatology (QIDS), clinician rating (QIDS-C), and self-report (QIDS-SR): a psychometric evaluation in patients with chronic major depression Biol Psychiatry 54 2003 573
17. A.T. Beck, C.H. Ward, M. Mendelson, J. Mock, and J. Eebgaugh An inventory for measuring depression Arch Gen Psychiatry 4 1961 561
18. A.H. Balen, J.S.E. Laven, S.L. Tan, and D. Dewailly Ultrasound assessment of the polycystic ovary: international consensus definitions Hum Reprod Update 9 6 2003 505 514
19. A.J. Stunkard, M.S. Faith, and K.C. Allison Depression and obesity Biol. Psychiatry 54 2003 330 337
20. L.M. Pastore, J.T. Patrie, W.L. Morris, P. Dalal, M.J. Bray, and Depression symptoms and body dissatisfaction association among polycystic ovary syndrome women J Psychosom Res 71 October (4) 2011 270 276
21. J.G. McCook, N.E. Reame, and S.S. Thatcher Health-related quality of life issues in women with polycystic ovary syndrome J Obstet Gynecol Neonatal Nurs 34 January-February (1) 2005 12 20
22. J.A. Barry, A.R. Kuczmierczyk, and P.J. Hardiman Anxiety and depression in polycystic ovary syndrome: a systematic review and meta-analysis Hum Reprod 26 9 2011 2442 2451
23. M. Timonen, I. Salmenkaita, J. Jokelainen, M. Laakso, P. Harkonen, and P. Koskela Insulin resistance and depressive symptoms in young adult males: findings Psychosom Med 69 2007 723 728
24. G.I. Papakostas, D. Ongur, D.V. Iosifescu, D. Mischoulon, and M. Fava Cholesterol in mood and anxiety disorders: review of the literature and new hypotheses Eur Neuropsychopharmacol 14 2004 135 142
25. W. Baischer, G. Koinig, B. Hartmann, J. Huber, and G. Langer Hypothalamic-pituitary-gonadal axis in depressed premenopausal women: elevated blood testosterone concentrations compared to normal controls Psychoneuroendocrinology 20 5 1995 553 559
26. A. Rassi, A. Barciela Veras, and M. dos Reis Prevalence of psychiatric disorders in patients with polycystic ovary syndrome Compr Psychiatry 51 2010 599 602
27. N.L. Rasgon, R.C. Rao, S. Hwang, L.L. Altshuler, S. Elman, and J. Zuckerbrow-Miller Depression in women with polycystic ovary syndrome: clinical and biochemical correlates J Affect Disord 74 May (3) 2003 299 304
28. E. Hollinrake, A. Abreu, M. Maifeld, B.J. Van Voorhis, and A. Dokras Increased risk of depressive disorders in women with polycystic ovary syndrome Fertil Steril 87 June (6) 2007 1369 1376
29. G.A. Fava, M. Fava, R. Kellner, E. Serafini, and I. Mastrogiacomo Depression, hostility and anxiety in hyperprolactinemic amenorrhea Psychother Psychosom 36 1981 122 128
30. J.A. Babb, L.M. Carini, S.L. Spears, and B.C. Nephew Transgenerational effects of social stress on social behavior, corticosterone, oxytocin, and prolactin in rats Horm Behav 65 April (4) 2014 386 393
31. P.W. Gold, F.K. Goodwin, and G.P. Chrousos Clinical and biochemical manifestation of depression. Relation to the neurobiology of stress N Engl J Med 319 348-353 1988 413 420
32. I. Heuser, A. Yassouridis, and F. Holsboer The combined dexamethasone/CRH test: a refined laboratory test for psychiatric disorders J Psychiatr Res 28 1994 341 356
33. F. Holsboer, and N. Barden Antidepressants and hypothalamic-pituitary-adrenocortical regulation Endocr Rev 17 1996 187 205
34. E.A. Young, R.F. Haskett, V. Murphy-Weinberg, S.J. Watson, and H. Akil Loss of glucocorticoid fast feedback in depression Arch Gen Psychiatry 48 1991 693 699